- Home
- YMAB vs PMTS Comparison
YMAB vs PMTS Comparison
Compare YMAB & PMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- PMTS
- Stock Information
- Founded
- YMAB 2015
- PMTS 2007
- Country
- YMAB United States
- PMTS United States
- Employees
- YMAB N/A
- PMTS N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- PMTS Finance Companies
- Sector
- YMAB Health Care
- PMTS Finance
- Exchange
- YMAB Nasdaq
- PMTS Nasdaq
- Market Cap
- YMAB 270.5M
- PMTS 316.9M
- IPO Year
- YMAB 2018
- PMTS 2015
- Fundamental
- Price
- YMAB $4.43
- PMTS $29.17
- Analyst Decision
- YMAB Buy
- PMTS Strong Buy
- Analyst Count
- YMAB 11
- PMTS 4
- Target Price
- YMAB $18.73
- PMTS $37.25
- AVG Volume (30 Days)
- YMAB 328.7K
- PMTS 35.4K
- Earning Date
- YMAB 03-04-2025
- PMTS 03-04-2025
- Dividend Yield
- YMAB N/A
- PMTS N/A
- EPS Growth
- YMAB N/A
- PMTS N/A
- EPS
- YMAB N/A
- PMTS 1.64
- Revenue
- YMAB $87,685,000.00
- PMTS $480,601,000.00
- Revenue This Year
- YMAB $20.07
- PMTS $8.62
- Revenue Next Year
- YMAB $8.76
- PMTS $7.15
- P/E Ratio
- YMAB N/A
- PMTS $17.88
- Revenue Growth
- YMAB 3.38
- PMTS 8.11
- 52 Week Low
- YMAB $4.25
- PMTS $16.08
- 52 Week High
- YMAB $17.78
- PMTS $35.19
- Technical
- Relative Strength Index (RSI)
- YMAB 34.59
- PMTS 47.88
- Support Level
- YMAB $4.65
- PMTS $28.25
- Resistance Level
- YMAB $5.25
- PMTS $30.60
- Average True Range (ATR)
- YMAB 0.30
- PMTS 1.14
- MACD
- YMAB 0.03
- PMTS 0.06
- Stochastic Oscillator
- YMAB 6.32
- PMTS 52.81
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.